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SUMMARY 
Thermolysin is irreversibly inhibited at pH 7.2 by the alkylating 
agents C1CH2C0-DL-(N-OH)Leu-OCH3 and 2-(N-bromoacetyl-N-hydroxyamino)-4-
methyl pentanonitrile. The inhibition reactions exhibit saturation 
kinetics with values of 7.5 and 0.80 mM respectively. Competitive 
inhibitors of thermolysin (P-Leu-Trp-OK and Z-Phe-OH) hindered the alky-
lation. The stoichiometry of the reaction was demonstrated to be 0.97 to 
14 
1 by use of C-labeled C1CH2C0-DL-(N-0H)Leu-0CH3. No change was observed 
in the amino acid analysis of the alkylated thermolysin. The inhibitor 
moiety could be removed with 1 mM NaOH or 1 M NH 20H, observations which 
support the existence of an ester linkage between the enzyme and inhibitor. 
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Degradation of thermolysin alkylated with C-labeled C1CH2C0-DL-(N-OH)Leu-
OCH^ with CN-Br demonstrated that the F^ fragment (residues 121-205) con­
tained the inhibitor moiety. The evidence indicates that the inhibitor 
binds to the active site of thermolysin with interaction of the hydroxamic 
acid functional group with the active site zinc atom. Subsequent alky-
lation of Glu-143 irreversibly inactivates the enzyme. Other alkylating 
agents lacking the hydroxamic acid such as BrC^CO-Phe-OCH^, BrCH2C0-L-
MeLeu-OCH^, and BrCH2C0-L-MeLeu-L-Ala-0CH3 did not react with enzyme. The 
inhibitor C1CH2C0-DL-(N-OH)Leu-OCH3 exhibited considerable specificity 
and would not inhibit the serine proteases chymotrypsin A^ and subtilisin 
BPN, while the neutral metalloproteases A and B from B_. subtilis were 
inactivated. Carboxypeptidase A was inactivated very slowly > ^ 
days). Haloacetyl-N-hydroxypeptides with the appropriate amino acid or 
vii 
peptide structures should be useful for the inhibition of other metallo-
proteases. 
A new method for the assay of the enzymatic activity of bacterial 
collagenase has been developed. The depsipeptide Z-Gly-Pro-Leu-OCH^CO-
Pro-NH^ is cleaved at the ester bond by clostridiopeptidase A. The 
enzymatic cleavage of the depsipeptide can be conveniently assayed by 
pH-stat titration. The K value for Z-Gly-Pro-Leu-0CHoC0-Pro-NHo and 
m 2 2 
clostridiopeptidase A was determined to be 1.3+0.1 mM at pH 7.5. The 
cleavage is inhibited by 1,10-phenanthroline as well as by a series of 
hydroxamic acid peptides, but not by the serine protease inhibitor 
ot-toluenesulfonyl fluoride. 
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CHAPTER I 
INTRODUCTION 
The development of inhibitors, in particular active site 
directed irreversible inhibitors, of the neutral protease thermolysin 
may be a significant step in the ultimate production of specific inhibi­
tors of the biologically more important metalloendoproteases. An ex­
ample is the enzyme collagenase which has been implicated in the debili­
tating disease arthritis (Harris and Krane, 1974). Collagenase has been 
found to participate in a variety of physiological processes, both 
beneficial and pathological. Specific irreversible inhibitors of these 
and other metalloendoproteases could be of potential therapeutic value, 
as well as aiding in the study of the active sites of these enzymes. 
An essential requirement for the design of active site directed 
inhibitors of any enzyme is at least a limited knowledge of the sub­
strate, binding properties. This permits the logical design of inhibitors 
of the enzyme through the conservative modification of a substrate, re­
sulting in a structure which will bind at the active site and interfere 
with catalysis. If enough detailed information is available on the mode 
of binding of substrates or inhibitors to the active site of an analogous 
model enzyme, then this knowledge can be applied to the synthesis of 
structures, not greatly resembling natural substrates, which may bind at 
the active site of a more complex enzyme and inhibit its catalytic activ­
ity. The design of inhibitors of mammalian collagenase appears best to 
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be approached through the latter method, owing to the complexity inherent 
in the triple helical structure of collagen, the enzyme's natural substrate. 
To avoid the complications of using mammalian collagenase from 
the start and to gain information into the behavior of metalloendopro­
teases in general, a model enzyme (thermolysin) was chosen as our initial 
target for inhibition. Thermolysin (EC 3. 4. 24. 4) is a neutral endo-
protease which requires a zinc atom at the active site for enzymatic ac­
tivity. The amino acid sequence (Titani j2t al. 1977b) and the X-ray 
structure (Matthews et al., 1972a, b; Colman et al., 1972) of the enzyme 
have been determined. Typical chelating reagents such as ethylenediami-
netetraacetic acid and 1,10-phenanthroline inhibit enzymatic activity. 
A series of potent active site directed reversible inhibitors containing 
the hydroxamic acid (Nishino and Powers, 1978) and phosphoramidate (Kam 
and Powers, unpublished results) functional groups have recently been 
synthesized. 
Kester and Matthews (1977b) have compared in detail the X-ray 
structures of the active sites of carboxypeptidase A and thermolysin. 
The tetrahedral coordination around the zinc of carboxypeptidase A is 
more distorted than in thermolysin. The coordination of the carbonyl of 
the scissile peptide bond to the zinc atom is almost linear for thermo­
lysin, while for corboxypeptidase A the same group is considerably tilted. 
There are significant differences between the positions of the catalyti-
cally important residues Glu-143 of thermolysin and Glu-270 of carboxy­
peptidase A relative to the scissile bond. Glu-270 is closer to the 
peptide bond cleaved than Glu-143. Two alternative mechanisms for the 
hydrolysis of peptide substrates by both enzymes have been proposed. In 
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the first mechanism, a glutamic acid (Glu-143), thermolysin, Glu-270, 
carboxypeptidase A) acts as a general base promoting the attack of a 
water molecule on the carbonyl carbon of the peptide bond cleaved, while 
in the second mechanism the glutamic acid acts as a nucleophile, attack­
ing the carbonyl directly forming an anhydride subsequently cleaved by 
water. The structural similarity of the active sites of thermolysin and 
carboxypeptidase A suggests closely related mechanisms for both enzymes. 
Kester and Matthews (1977b) determined through model building ex­
periments, based on the mode of binding of dipeptides (1977a), that direct 
nucleophilic attack by Glu-143 on the carbonyl bond of the substrate is 
stereochemically implausible. The stereochemical restrictions observed 
for thermolysin are not present in the case of carboxypeptidase A, in 
which the carbonyl carbon of the pseudo-substrate glycyl-tyrosine binds 
o 
1.4A closer to the glutamate oxygen than does an analogous dipeptide to 
thermolysin. 
Weaver elt al. (1977) proposed that the tight binding of the com­
petitive inhibitor phosphoramidon (Suda et al., 1973; Komiyama et al., 
1975) to thermolysin is the result of its being a tetrahedral transition 
state analog, very similar to the intermediate which would be formed by 
attack of a water molecule, promoted by Glu-143, on the carbonyl carbon 
of the scissile bond of a substrate. The observation that CH^-O-PO^-Leu-
NH 2*K (Kj in the mM range) is a significantly poorer inhibitor of thermo­
lysin than is PO^-Leu-NH^* 2K (K^ . in the u M range) (Kam and Powers, un­
published results) argues against these inhibitors being simply transition 
state analogues. 
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Evidence for the general base mechanism for carboxypeptidase A 
hydrolysis of peptide substrates has been provided by Breslow and Wernick 
(1976, 1977) through oxygen-18 exchange studies; however, they do propose 
that ester cleavage by this enzyme is through anhydride formation. 
The active site His-231 of thermolysin has been suggested (Kester 
and Matthews, 1977a; Weaver et al., 1977) to assist peptide cleavage by 
donating a proton to the leaving amino group. Model building experiments 
(Kester and Matthews, 1977b) indicate that in the transition state the 
newly tetrahedral nitrogen of the scissile bond moves to within about 
o o 
3.5A of N „ of His-231. A small movement (0.5A) of His-231 would then 
bring the imidazole into the expected position for direct proton trans­
fer. However, proton transfer via a water molecule cannot be ruled out. 
The role of the active site Tyr-248 of carboxypeptidase A in catalysis 
remains uncertain. This residue appears to be the only candidate for 
proton donation at the active site of carboxypeptidase A analogous to 
His-231 of thermolysin. 
From structural considerations alone, the close positional corres­
pondence of the zinc atoms and the respective glutamic acid residues of 
both enzymes suggest that this stereochemical juxtaposition is vital to 
catalysis. There appears to be no absolute requirement for the involve­
ment of a histidine or a tyrosine in hydrolysis catalyzed by these two 
proteases. 
In the design of an active site directed irreversible inhibitor 
(an affinity label) of thermolysin, the considerations discussed above 
concerning the active sites of two zinc containing proteases were 
valuable guides as to where an alkylating functional group should be 
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located in a potential inhibitor with a reasonable expectation of 
labeling either the Glu-143 or His-231 residues. A lead in this direc­
tion appeared to be the compounds used by Hass and Neurath (1971a, b) to 
label the Glu-270 of carboxypeptidase A. Carboxypeptidase B is 
BrCH2CO-L-Phe-OH1 
BrCH2CO-L-(N-CH3>Phe-OH 
modified by N-Bromoacetyl-D-arginine, a reagent that stoichiometrically 
reacts with the active site glutamic acid residue (Plummer, 1971; Kimmel 
and Plummer, 1972, Sokolovsky and Zisapel, 1974). The side chains of 
Tyr-248 and a methionine residue of carboxypeptidase B are modified re­
spectively by bromoacetamido-butylguanidine (Plummer, 1969) and N-bromo-
acetyl-p-aminobenzyl-L-succinic acid (Zisapel and Sokolovsky, 1974). 
Since thermolysin and carboxypeptidase A have similar primary substrate 
binding requirements for a bulky hydrophobic residue occupying the S-
1Abbreviations used: BrCH2CO-Phe-OCH3, N-bromoacetyl-L-phenyl-
alanine methyl ester; BrCH^O-L-MeLeu-OCH^, N-bromoacetyl-L-N-methyl-
leucine methyl ester; BrCH^O-L-MeLeu-L-Ala-OCH^, (N-bromoacetyl-L-N-
methylleucyl-L-alanine methyl ester; ClCH2CO-(N-OH)Leu-OCH3), N-chloro-
acetyl-DL-N-hydroxyleucine methyl ester; DMF, dimethylformamide; FA-Gly 
L-Leu-NH2, furylacryloylglycycl-L-leucinamide; Hepes, N-2-hydroxyethyl-
peperazine-N-2-ethanesulfonic acid; P-Leu-Trp-OK, N-Phosphoryl-L-leucyl-
L-tryptophan tripotassium salt; Pipes, piperazine-N, N-bis(ethanesulfonic 
acid); Tris, tris (hydroxymethyl) aminomethane. 
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(notation of Schechter and Berger, 1967) subsite, modification of the 
inhibitors described by Hass and Neurath (thermolysin does not "like" a 
free carboxyl group at the site) were examined as possible affinity 
labels of thermolysin with disappointing results. 
This thesis reports the unsuccessful attempt to extend the class 
of compounds developed by Hass and Neurath as possible inhibitors of the 
metalloendoprotease thermolysin, and the successful utilization of halo-
acetyl-N-hydroxy derivates of amino acids as affinity labels of thermo­
lysin and the 13. subtilis neutral proteases A and B. The results of this 
work has been reported elsewhere (Rasnick, 1978; Rasnick and Powers, 1978). 
Potentially, these structures could be incorporated into specific active 
site directed irreversible inhibitors of the bacterial and mammalian 
collagenases. 
In order to determine the effectiveness of the inhibitors 
synthesized for use with collagenase, a method for the convenient and 
reliable assay of the enzymefs activity is desirable. Unfortunately, 
there is no such method at present for the assay of the mammalian enzyme. 
The assay of bacterial collagenase (Clostridiopeptidase A) activity, using 
the commercially available substrate 4-phenylazobenzyloxycarbonyl-L-prolyl-
L-leucyl-glycyl-L-prolyl-D-arginine, is cumbersome and not very sensitive. 
As a result of the close relationship between the efficient development 
of inhibitors and routine and reliable enzyme assays, we include a report 
of a new method for the assay of bacterial collagenase enzymatic activity. 
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CHAPTER II 
MATERIALS AND METHODS 
The following enzymes were obtained from the Sigma Chemical 
Company: thermolysin purified as described by Titani et al. (1972a); 
carboxypeptidase A used as an aqueous suspension containing a trace of 
toluene; subtilisin BPN Type VII was used without further purification; 
Clostridiopeptidase A Type VI. Crystalline chymotrypsin A^ (Worthington 
Biochemical Corp.) was also used without further purification. A mixture 
of neutral proteases A and B from _B. subtilis was kindly provided by 
Dr. J. Feder of Monsanto and separated and purified by Dr. Norikazu 
Nishino on an affinity column (HONHCOCH (CHoC,Hc)C0-Ala-Gly-Affi-Gel 101, 
Affi-Gel 101 was supplied by Bio-Rad) in our laboratory. 
Other commercial reagents of the highest quality available were 
obtained as follows: chloroacetic acid, glycolic acid, and bromoacetyl 
bromide (Aldrich Chemical Co.); furylacryloylglycyl-L-leucinamide 
(FA-Gly-Leu-N^) (Vega-Fox Biocheraicals); N-jt-butyloxycarbonyltyrosine-p-
nitrophenyl ester (Boc-Tyr-ONp) (Bachem Fine Chemicals); N-carbobenzyloxy-
glycylphenylalanine (Z-Gly-Phe-OH) and Z-Phe-OH (Pierce Chemical Co.); 
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(1- C) chloroacetic acid (New England Nuclear); cyanogen bromide (East­
man Organic Chemicals) was stored in a sealed desiccator at 4° when not 
in use. L-Phenylalanine methyl ester hydrochloride was synthesized by 
Dr. R. Boone in our laboratory. Sephadex G-75, medium, was purchased 
from the Sigma Chemical Company. Sephadex G-25, fine, was obtained from 
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Pharmacia Fine Chemicals and Bio-Gel P-100 (100-200 mesh) from Bio-Rad 
Laboratories. N-Phosphoryl-L-leucyl-L-tryptophan tripotassium sale (P-
Leu-Trp-OK) and N-phosphoryl-L-isoleucyl-L-alanine tripotassium salt 
(P-Ile-Ala-OK) were synthesized by Dr. Chih-Min Kam of our group. Z-Gly-
Pro-Leu-NHOH, Gly-Pro-Leu-(N-OH)Gly-ProOH, Boc-Gly-Pro-Leu-(N-OH)GLy-ProOH, 
HONHCOCH2CO-ProNH2, Boc-Gly-Pro-Leu-(N-OH)Gly-OCH2CH3, Z-Gly-Pro-Leu-OH, 
Z-Gly-Gly-LeuNHOH, Z-Gly-LeuNHOH, HSCH 2CH(CH 2C 6H 5)CO-Ala-GlyNH 2, and 
H0NHC0CH(i-Bu)C0-Ala-GlyNH2 were synthesized by Dr. Norikazu Nishino of 
our group. 
Analytical Procedures. Peptidase activity of thermolysin and 
neutral proteases A and B were determined by following the decrease in 
absorption at 345 nm due to the enzymatic hydrolysis of a 2 ml solution 
of FA-Gly-Leu-NH2 (1.2 mM) as described by Walsh et al. (1975) with the 
exception that Tris buffer was used in place of Hepes. Protein concen­
trations were determined by measuring the absorption at 280 nm using a 
Beckman 25 thermostated spectrophotometer. A molar absorptivity of 
66,400 M 1 ci 1 was used for thermolysin (Ohta et al., 1966; Titani et^  
al., 1972b). The concentrations of neutral proteases A and B, and chymo-
1% -1 trypsin A^ were similarly determined, e ^QQ ~ 14.8 and 14.7 cm (Walsh 
et al., 1975) and e 2 g 2 = 50,000 M _ 1 cm" 1 (Wilcox, 1970) respectively. 
1% 
The concentration of clostridiopeptidase A was estimated using £^80 = 
18.0 (Worthington Enzyme Manual, 1972). 
Radioactivity was measured with a Beckman LS-100C liquid scintil­
lation spectrometer. An efficiency of 52% was observed for 1 ml aqueous 
samples dispersed in 10 ml of Triton X-100 (Lieberman and Moghissi, 1970). 
Elemental analysis was performed by Atlantic Microlab, Atlanta, Georgia. 
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Infrared spectra were measured on a Perkin Elmer 457 instrument. Proton 
magnetic resonance (pmr) spectra were taken on a Varian T-60 instrument. 
Quantitative amino acid analysis was performed in the laboratory of Dr. 
J. Travis (University of Georgia) on 24 hr. hydrolysates (6N HC1). Thin 
layer chromatography was performed on Merck silica gel G plates with the 
1 2 
solvent systems; , chloroform-methanol (10:1, v/v), R^ , cyclohexane-
3 4 
ethyl acetate (1:3, v/v), R^ , chloroform-methanol (5:1, v/v); R^ , 
n-butanol-acetic acid-water (4:1:1, v/v). 
N-Bromoacetyl-L-phenylalanine methyl ester. To a suspension of 
L-phenylalanine methyl ester hydrochloride (10.0 g, 46.5 mmol) in 250 ml 
of ethyl acetate were added bromoacetyl bromide (9.40 g, 46.5 mmol) and 
triethylamine (9.40 g, 93.0 mmol) at -10° with stirring 30 min at -5°. 
The reaction was quenched with water (200 ml). The organic phase was 
separated and washed with 100 ml of 1.0 M HC1, 100 ml of 0.1 M NaHC0 3, 
and 100 ml of water and then dried over anhydrous magnesium sulfate. The 
ethyl acetate was removed by evaporation to give a deep red oil which was 
taken up in 30 ml of ether. Crystals formed following the addition of 
petroleum ether. Yield was 2.90 g (28%), mp 83-84°, R f 1 0.92, R 2 0.77. 
This compound had been prepared by a different method, mp 80-82° 
(Williams, 1952). 
The pmr (CDC13) spectrum showed peaks at 67.2 (6H, s, Ph + NH). 
4.8 (1H, m, N-CH-), 3.8 (2H, s, BrCH 2-), 3.7 (3H, s, CILy-0), 3.2 (2H, d, 
Ph-CH_2-). 
N-Bromoacetyl-L-N-methylleucine methyl ester. To a suspension of 
L-N-methylleucine methyl ester hydrobromide (410 mg, 1.7 mmol) (prepared 
by treating N-carbobenzyloxy-L-N-methylleucine methyl ester (Okamoto e_t 
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al., 1974) with a 30% solution of HBr in acetic acid) in 50 ml of ethyl 
acetate were added bromoacetyl bromide (350 mg, 1.7 mmol) and N-methyl-
morpholine (350 mg, 3.4 mmol) at room temperature with stirring 24 hr. 
Water (50 ml) was then added and the organic phase was separated and 
washed with 50 ml of 1.0 M HC1, 50 ml of 0.1 M NaHC0 3, and 50 ml of 
water and then dried over anhydrous magnesium sulfate. The ethyl acetate 
was removed by evaporation to give a colorless oil 270 mg (57%). The ir 
(neat) had absorption bands at 1740 (ester CO) and 1660 cm ^ (amide CO). 
The pmr (CDC13) spectrum showed peaks at 65.2 (1H, t, N-CH-), 
4.0 (2H, s, BrCH 2), 3.7 (3H, s, CH 3-0), 3.0 (3H, s, CH 3N), 2.0-1.2 (3H, 
m, CH 2CH), 0.9 (6H, d, CH(CH 3) 2). 
Anal, calcd for C 1 0 H 1 8 B r N 0 3 : C, 42.87; H, 6.48; N, 5.00 Found: 
C, 42.75; H, 6.34; N, 5.21. 
N-Bromoacetyl-L-N-methylleucyl-L-alanine methyl ester was similar­
ly prepared by treating L-N-methylleucyl-L-alanine methyl ester hydro-
bromide (192 mg, 0.62 mmol) with bromoacetyl bromide (125 mg, 0.62 mmol) 
to give 140 mg (62%) of an oil. 
The pmr (CDC13) spectrum showed peaks at 66.9 (1H, d, HN), 5.2 
(1H, t, NCHCH 2), 4.4 (1H, m NHCHCH 3), 4.0 (2H, s, BrCH 2), 3.8 (3H, s, 
CH 3-0), 3.0 (3H, s, CH 3-N), 1.7 (3H, m CH 2CH(CH 3)^ , 1.2 (3H, d, NHCHCH 3), 
0.9 (6H, d, (CH 3) 2). 
2-(N-Bromoacety1-DL-N-hydroxyamino)-4-methylpentanonitrile. To 
DL-2-hydroxyamino-4-methylpentanonitrile (1.73 g, 13.5 mmol) (Neelakantan 
and Hartung, 1958) in 20 ml of acetonitrile was added bromoacetyl bromide 
(1.36 g, 6.75 mmol) at room temperature. The reaction was stopped after 
2 hr. The acetonitrile was removed by evaporation and the residue was 
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dissolved in 100 ml of chloroform, washed with 50 ml of 0.1 M NaHCO^, 50 
ml 1.0 M HC1, and 50 ml water then dried over anhydrous magnesium sulfate. 
The CHCl^ was removed by evaporation to leave 1.28 g of a yellow oil. 
The oil was chromatographed on 50 g of silica gel 60 and eluted with 0.5% 
ethyl acetate in chloroform to give 830 mg (50%) of a colorless oil which 
produced an intense red color when treated with 10% methonolic ferric 
chloride. The oil decomposed upon attempted distillation at 120° and 
0.05 mm pressure. The ir (neat) had absorption bands at 3220 (OH), 2250 
(CN), and 1655 cm" 1 (amide CO); R f 1 0.80, R f 2 0.55. 
The pmr (CDCl^), spectrum showed peaks at 65.6 (1H, t, -CH-CN), 
4.2 (2H, s, BrCH 2~), 2.2-1.5 (3H, m, CH^CH), 0.9 (6H, d, CH(CH 3) 2). 
N-Chloroacetyl-DL-N-hydroxyleucine methyl ester was prepared by 
the procedure of Cook and Slater (1956); mp 80-80.5° (lit. mp 81°). 
The pmr (CDCl^) spectrum showed peaks at 65.3 (1H, t, N-CH), 4.4 
(2H, s, C1CH - ) , 3.8 (3H, s, CH - 0 ) , 2.2-1.4 (3H, m, CH CH), 0.9 (6H, 
d, CH(CH 3) 2). 
Anal, calcd for CoH-,ClN0.: C, 45.48; H, 6.78: N, 5.89. Found: 
C, 45.50; H, 6.82; N, 5.88. 
a - Bromoisocaproylhydroxamic acid. To a - bromoisocaproic acid 
(1.0 g, 5.1 mmol) at 0° were added DCC(1.1 g, 5.1 mmol) and N-hydroxysuc-
cinamide (0.59 g, 5.1 mmol) in 50 ml dioxane. The mixture was stirred 
1 hr at 0° and 2 hr at room temperature. The DCU was filtered off and 
to the filtrate was added 1 equivalent of NH 20H in 75 ml DMF. This 
solution was stirred 10 hr at room temperature. The dioxane and DMF 
were evaporated off to give an oil which turned a 10% solution of methan-
olic ferric chloride red. The oil was crystallized from ether-petroleum 
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ether to give 537 mg (50%), mp 121-122°. 
Anal, calcd for C.H 1 0BrN0 0: C, 34.31; H, 5.76; N, 6.67. Found: 6 12 2 
C, 34.36; H, 5.79; N, 6.66. 
N-(3-methvl-l-methoxycarbonvlbutvl)-3-isobutyl-oxaziridine. To 
isovaleriminoleucine methyl ester (2.09 g, 9.8 mmol) in 5 ml CH 2C1 2 was 
added m-chloroperbenzoic acid (85%) (1.69 g, 9.8 mmol) in 15 ml CH 2C1 2 
in portions with cooling to -5-0° over 1.5 hr, then stirred overnight at 
room temperature. The solution was filtered and the filtrate was washed 
with 20 ml of 1.0 M HC1, 20 ml of saturated NaHC0 3 solution, and 20 ml of 
water, then dried over anhydrous magnesium sulfate. The CH 2C1 2 was 
evaporated off to give 2 g (89%) of an oil. The oil was purified by 
distillation, bp 82-83° (0.08 mm) 
The nmr (neat) showed peaks at 63.9 (1H, t, N-CH-), 3.7 (3H, s, 
A 
0CH 3), 2.8 (1H, m , V — N ) , 2.2-1.2 (6H, m, 2(CH -CH)), 0.9 (12H, m, 
2(CH 3) 2). The compound oxidized iodide to iodine in acetic acid. 
Anal, calcd for C 1 2 H 2 3 N ° 3 : C» 6 2 * 8 5 ; H> 1 0 * 1 1 ; N» 6 ' 1 1 ' F o u n d : 
C, 62.90; H, 10.08; N, 6.12. 
N-Benzylidene-DL-leucine-N-oxide methyl ester. Anti-benzaldoxime 
(2.02 g, 16.7 mmol) (Polonski and Chimiak, 1976) and DL-a-bromoisocaproic 
acid methyl ester (3.5 g, 16.7 mmol) were added to a 20 ml solution of 
methanol containing sodium (0.38 g, 16.7 mmol). The solution was stirred 
overnight at room temperature. The methanol was evaporated off and the 
residue was treated with 15 ml water and the pH was adjusted to 7 with 
0.1 M HC1. The aqueous solution was extracted with 20 ml of chloroform. 
The organic layer was dried over anhydrous magnesium sulfate. The chloro­
form was evaporated off and the residue was crystallized from ether to 
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give 1.0 g (24%), mp 106-108°. 
The nmr (CDC13) showed peaks at 68.2 (2H, m Ph-H), 7.5 (4H, m, 
Ph-CH=), 4.8 (1H, q, N-CH-), 3.8 (3H, s, 0CH 3), 2.5-1.3 (3H, m C ^ C H - ) , 
0.9 (6H, d, C(CH 3) 2). 
Anal, calcd for C 1 4 H 1 9 N 0 3 : c» 67.45; H, 7.68; N, 5.62. Found: 
C, 67.39; H, 7.69; N, 5.63. 
N-Carbobenzyloxy-glycyl-L-proline. To N-carbobenzyloxyglycine 
(14.9 g, 71.5 mmol) in methanol (150 ml) at -5° was added pyridine (5.65 g, 
71.5 mmol) and thionyl chloride (8.51 g, 71.5 mmol). The reaction mixture 
was stirred 30 min at 0° followed by the addition of proline (8.22 g, 
71.5 mmol) in 50 ml methanol and pyridine (5.65 g, 71.5 mmol) at 0°. The 
reaction mixture was allowed to warm to room temperature with stirring 1 
hr more. The methanol was evaporated off and the residue was crystallized 
from ethyl acetate to give 6.9 g (31.5%), mp 154-155° (Lit. mp 155-157°, 
Goodman and Stueben, 1962). 
Glycolyl-L-prolinamide. To glycolic acid (1.52 g, 20 mmol), pro­
line methyl ester hydrochloride (3.63 g, 22 mmol), N-hydroxybenzotriazole 
(0.27 g, 2 mmol), and triethylamine (3.1 ml, 22 mmol) in 100 ml THF at 0° 
was added DCC (4.12 g, 20 mmol) and stirred 1 hr at 0°, then set aside 12 
hr at 4°, followed by stirring 1 hr at room temperature. The DCU and 
triethylamine hydrochloride were removed by filtration and the THF of the 
filtrate was removed by evaporation. The residue was treated with ethyl 
acetate (30 ml) and filtered. The ethyl acetate was removed by evapora­
tion to give an oil which was treated with methanol saturated with ammonia 
(100 ml) and allowed to stand at room temperature for 20 hr. The methanol 
and ammonia were removed by evaporation leaving an oil which was 
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crystallized from methanol-ether to give 1.82 g (53%), mp 145-146°. The 
ir (nujol) had peaks at 3420 and 3100 (OH and HN stretch) and 1640 cm" 1 
(amide CO); R f 3 0. 26. 
The nmr (DMSO-d,) had peaks at 67.2-6.6(2H, d, N H 0 ) , 4.5-3.6 
(3H, m, HO-CH 2-+N-CH-), 3.3 (3H, m, N-CH_2+0H), 1.8 (4H, m, -CH^-CH^-CH^ 
N-). 
Anal, calcd for C 7 H 1 2 N 2 ° 3 : C ' 4 8 * 8 3 ; H» 7 - 0 2 » N> 16.27. Found: 
C, 49.04; H, 7.11; N, 16.42. 
N-t-Butyloxycarbonyl-L-leucyl-glycolyl-L-prolinamide was prepared 
by the method of Shimohigashi et al. (1977) to give 1.44 g (49%). The 
compound was used without characterization. 
N-Carbobenzyloxy-glycyl-L-prolyl-L-leucyl-glycolyl-L-prolinamide 
(Z-Gly-Pro-Leu-OCH2CO-Pro-NH2). To N-carbobenzyloxy-glycyl-L-proline 
(1.53 g, 5.0 mmol) in 20 ml THF at -20° was added N-methylmorpholine 
(0.50 g, 5.0 mmol) and isobutylchloroformate (0.58 g, 5.0 mmol). After 
stirring 5 min at -20° L-leucyl-glycolyl-L-prolinamide hydrochloride 
(1.6 g, 5.0 mmol) (prepared by treating N-j^-butyloxycarbonyl-L-leucyl-
glycolyl-L-prolinamide with 2.7 M HC1 in dioxane at room temperature for 
30 min followed by evaporation of the HC1 and dioxane) in 15 ml DMF and 
N-methylmorpholine (0.50 g, 5.0 mmol) were added at -20°. The mixture 
was stirred 1 hr at -20° and overnight at room temperature. The reaction 
was filtered and the filtrate was evaporated to a residue which was taken 
up in 40 ml chloroform followed by washing with saturated NaHCO^ solution 
(15 ml), and water (15 ml), then dried over anhydrous magnesium sulfate. 
The chloroform was removed by evaporation and the residue was crystallized 
3 
from ethyl acetate-ether to give 1.4 g (49%) mp 109-113°; R 0.65. 
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The nmr (CDC13) showed peaks at 67.3 (6H, s, Ph-H+NH), 6.8 
(1H, s, NH), 5.9 (2H, s, NH ) , 5.1 (2H, s, Ph-CH^, 4.6 (5H, m, 3(N-CH)+ 
OCH 2), 4.0 (2H, d, NH-CH 2), 3.5 (4H, m, 2(-N-CH ), 2.4-1.5 (11H, m, 
2(-NCH-CH 2CH 2)+CH 2CH(CH 3) 2), 0.9 (6H, d, CH(CH 3) 2). 
Anal, calcd for C 0 0 H 0 o N c 0 o ; C, 58.63; H, 6.85; N, 12.21. Found: 2o 39 5 o 
C. 58.21; H, 6.94; N. 12.08. 
N-t-Butyloxycarbonyl-glycyl-L-prolinamide. To N-t-butyloxy-
carbonyl-glycine (9.26 g, 53 mmol) in 175 ml THF at -20° was added 
N-methylmorpholine (5.35 g, 53 mmol) and isobutylchloroformate (7.26 g, 
53 mmol). After stirring 5 min at -20° proline methyl ester hydrochloride 
(8.75 g, 53 mmol) in 20 ml chloroform and N-methylmorpholine (5.35 g, 
53 mmol) were added at -20°. The reaction was allowed to reach room 
temperature (about 20 min). The mixture was filtered and the filtrate 
was evapoarted to a residue which was taken up in 100 ml chloroform, 
washed with 50 ml of saturated NaHC0 3 solution and 50 ml of water, then 
dried over anhydrous magnesium sulfate. The chloroform was evaporated 
off and the residue was taken up in 150 ml of methanol saturated with 
ammonia and allowed to stand 2 days at room temperature. The methanol 
and ammonia were removed by evaporation to leave a residue which was 
crystallized from 100 ml ether to give 3.8 g (26.5%), mp 145-147°. 
The nmr (CDC13) showed peaks at 67.0 (1H, s, NH), 6.1 (1H, s, 
NH), 5.7 (1H, t, NH-CH 2), 4.6 (1H, t, -N-CH-CH ), 4.0 (2H, d, NH-CH ) , 
3.6 (2H, m, -N-CH - ) , 2.2 (4H, m, -N-CH 2CH 2CH 2), 1.5 (9H, s, 0-C(CH 3) 3). 
N-t-Butyloxycarbonyl-L-leucyl-glycyl-L-prolinamide. To N-t-butyl-
oxycarbonyl-L-leucine (1.28 g, 5.5 mmol) in 50 ml THF at -20° were added 
N-methylmorpholine (0.56 g, 5.5 mmol) and isobutylchloroformate (0.76 g, 
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5.5 mmol). After stirring 5 min. at -20° glycyl-L-prolinamide (1.5 g, 
5.5 mmol) (prepared by treating N-_t-butyloxycarbonyl-glycyl-L-prolinamide 
with HCl-dioxane for 30 min followed by evaporation of the HC1 and diox­
ane) in 40 ml DMF and N-methylmorpholine (0.56 g, 5.5 mmol) were added at 
-20°. The reaction was allowed to warm and stand at room temperature 
overnight. The mixture was filtered and the filtrate was evaporated to 
a residue which was taken up in 80 ml chloroform and washed with 20 ml 
saturated NaHCO^ solution and 20 ml water, then dried over anhydrous 
magnesium sulfate. The chloroform was evaporated off and the residue was 
crystallized from 100 ml ether to give 0.97 g (46%), mp 132.5-134°. 
The nmr (CDC13) had peaks at 67.6 (1H, s, NH), 7.4 (1H, s, NH), 
6.7 (1H, s, NH), 6.3 (1H, m, NH-CH 2), 4.5 (2H, m, -N-CH-CH 2-+NH-CH-CH 2), 
4.1 (2H, d, NH-CH 2), 3.6 (2H, m, -N-CH_2) , 2.1 (4H, m, -N-CH^CH^-CH^,-) , 
1.7 (3H, m, CH CH), 1.4 (9H, s, 0-C(CH 3) 3), 0.9 (6H, d, CH(CH 3) 2). 
N-Carbobenzyloxy-glycyl-L-prolyl-L-leucyl-glycyl-L-prolinamide 
(Z-Gly-Pro-Leu-Gly-ProNH2). To N-carbobenzyloxy-glycyl-L-proline (0.40 g, 
1.3 mmol) in 20 ml DMF at -12° were added N-methylmorpholine (150 ul) 
N-hydroxybenzotriazole (18 mg, 0.13 mmol), L-leucyl-glycyl-L-prolinamide 
hydrochloride (0.42 g, 1.3 mmol) and DCC (0.27 g, 1.3 mmol). The reaction 
was stirred 4 hr at 0° and overnight at room temperature. The mixture 
was filtered, and the filtrate was evaporated to a residue which was 
treated with 20 ml water and filtered. The filtrate was treated with 
Rexyn 1-300 for 1.5 hr and filtered. The water was removed by evapora­
tion and the residue was pumped dry over ? 20^ to give 0.144 g (19.5%) mp 
201-206°. Recrystallized from methanol-ether, mp 209-211°. 
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The nmr (DMSO-dJ showed peaks at 67.4 (5H, s, Ph-H), 7.2-6.9 
o — 
(5H, d, 3 (NH)+NH 2), 5.1 (2H, s, Ph-CH •), 4.3 (2H, s, 2(-N-CH-), 3.9 
(4, m, 2(NH-CH 2), 3.7-3.2 (5H, m, 2(-N-CH2)+NH-CH-), 1.9 (8H, m, 
2(-N-CH 2CH 2-CH 2), 1.5 (3H, m, CH 2CH), 0.9 (6H, s, CH(CH 3) 2). 
Anal, calcd for C 2 8 H 4 0 N 6 ° 7 : C » 5 8 ' 7 3 ; H » 7 - 0 5 J N» 14.68. Found: 
C, 58.99; H, 7.01; N, 14.69. 
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N-(1- C) Chloroacetyl-DL-N-hydroxyleucine methyl ester. (1- C) 
Chloroacetic acid (2.3 mg, 41.8 mCi/mmol) and unlabeled chloroacetic 
acid (160 mg, 1.7 mmol) were dissolved in 1.5 ml of dry THF. To this 
solution at -5° were added pyridine (150 yl) and thionyl chloride (150 
yl). The reaction was protected with a calcium chloride drying tube and 
allowed to proceed 1 hr at room temperature. The solution was filtered 
and to the filtrate at 0° we*e added 200 mg of solid NaHCO^ and DL-N-hyd-
roxyleucine methyl ester (410 mg, 2.55 mmol) (Cook and Slater, 1956) in 
3 ml of dry THF. The solution was allowed to stand 30 min at room temper­
ature. Chloroform (25 ml) was added to the reaction solution followed by 
washing with 15 ml of saturated NaHC0 3 solution, 15 ml 1.0 M HC1, and 15 
ml water then dried over anhydrous magnesium sulfate. The THF and chloro­
form were removed by evaporation to leave an oil which was taken up in 5 
ml ether. Crystallization was initiated by the addition of petroleum 
ether. The overall yield was 196 mg (49%); mp 80-80.5°. The compound 
produced an intense red color when treated with 10% methanolic ferric 
chloride. The measured specific activity was 0.53 mCi/mmol. 
Treatment of Thermolysin with BrCH2CO-Phe-OCH3, BrCH2CO-L-MeLeu-
0CH 3 and BrCH2CO-L-MeLeu-L-Ala-OCH3. The procedures for treating thermo­
lysin with all of the alkylating agents were the same. To a 1 ml solution 
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of the enzyme (0.10 M Tris, 0.01 M CaCl 2 > pH 7.2) at 25° was added 50 yl 
of a dimethylformamide (DMF) solution of the alkylating agent. The final 
concentrations were 0.19 uM and 0.10 mM for the enzyme and alkylating 
agent respectively. Incubation was continued at least 48 hr. Aliquots 
(50 yl) of the incubating solution were periodically assayed for enzyme 
activity. A solution containing the enzyme but no alkylating agent was 
treated similarly. 
Treatment of Thermolysin with 2-(N-Bromoacetyl-N-hydroxamino)-4-
methylpentanonitrile. To 1 ml solutions of thermolysin in the above Tris 
buffer at 25° were added 50 yl of DMF solutions of inhibitor at the 
appropriate concentrations. The final inhibitor concentrations ranged 
from 0.87 to 0.12 mM, the enzyme concentration was 0.30 uM, and the final 
DMF concentration was 5%. Aliquots (50 yl) from each incubating solution 
were periodically assayed for residual enzyme activity and compared with 
a control enzyme solution lacking the inhibitor. 
Treatment of Thermolysin and the Neutral Proteases A and B with 
ClCH2CO-DL-(N-OH)Leu-OCH3. To 1 ml solutions of the appropriate enzyme 
at 25° were added 50 yl of DMF solutions of inhibitor at the appropriate 
concentrations. The final inhibitor concentrations with thermolysin 
ranged from 10.5 to 2.1 mM; for neutral proteases A and B the concentra­
tion of the inhibitor was 8.4 mM. The final concentration of thermolysin 
was 5.4 yM; and for neutral proteases A and B the final concentrations 
were 0.67 and 0.31 mg/ml respectively. 
The amino acid analyses for both purified alkylated and nonalky-
lated thermolysin were performed after chromatography on Sephadex G-25. 
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Treatment of Thermolysin with g-Bromoisocaproylhydroxamic acid. 
A thermolysin solution (1 ml) was treated similarly with 50 yl of a DMF 
solution of a-bromoisocaproylhydroxamic acid to give final enzyme and 
inhibitor concentrations of 5.4 uM and 10 mM respectively. The incubation 
proceeded 3 days. 
Treatment of Thermolysin with N-(3-methyl-l-methoxycarbonylbutyl)-3-
isobutyl-oxaziridine and N-Benzylidine-DL-leucine-N-oxide methyl ester. A 
thermolysin solution (1 ml) was again treated similarly with 50 yl of a 
DMF solution of the appropriate inhibitor to give a final enzyme concen­
tration of 5.0 uM and inhibitor concentrations of 2 mM each. Incubation 
proceeded 3 days. 
Treatment of Carboxypeptidase A with C1CH2C0-DL-(N-0H)Leu-0CH3. 
To a 1 ml solution of carboxypeptidase A (0.46 mg/ml, 1.0 M NaCl, 5 mM 
K^HPO^, pH 7.5) was added 50 yl of a methanolic solution of the alkylat­
ing agent to give a final inhibitor concentration of 1.0 mM. This solu-
rion was incubated at 25° for 3 days along with a control solution con­
taining the enzyme and 50 yl of methanol. Periodically 50 yl aliquots 
were assayed for residual enzyme activity by following the hydrolysis of 
a 2 ml solution of Z-Gly-Phe (1.2 mM, 0.45 M KC1, 0.05 M Tris, pH 7.5) 
spectrophotometrically at 223 nm. 
Treatment of Chymotrypsin A^ and Subtilisin BPN with C1CH2C0-DL-
(N-OH)Leu-OCH . A 1 ml solution of chymotrypsin A (0.10 M Hepes, 1.0 M 
NaCl, pH 7.5) and 50 yl of a methanolic solution of the alkylating agent 
were mixed together to give final enzyme and alkylating agent concentra­
tions of 0.93 yM and 1.0 mM respectively. This solution was incubated 
at 25° for 3 days along with a control lacking the alkylating agent. 
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Periodically 50 yl aliquots of these solutions were assayed for residual 
enzyme activity by their addition to 2 ml solutions containing 50 yM Boc-
Tyr-ONp (0.05 M citrate, 1.0 M NaCl, pH 6.5) and following the increase 
in absorption of each at 347.5 nm. 
A 1 ml solution of subtilisin BPN (0.10 mg/ml, 5.0 mM l^HPO^, 1.0 
M NaCl, pH 7.5) was treated with the alkylating agent in exactly the same 
manner as chymotrypsin A to give a final enzyme concentration of 95 yg/ml. 
a 
The assay buffer contained 0.01 M K^HPO. instead of citrate. 
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pH Dependence of the Inactivation of Thermolysin. The buffers 
used were: Pipes (pH 6.00) Hepes (pH 6.50-7./0), and Tris (pH 8.00-8.95); 
all were 0.10 M and contained 0.01 M CaCl 2. 
Thermolysin (4.2 yM) was incubated at 25° in the appropriate 
buffer with ClCH2CO-DL-(N-OH)Leu-OCH3 (2.3 mM) containing 5% DMF. Period­
ically 50 yl aliquots were taken and assayed for residual enzyme activity. 
Active Site Protection of Thermolysin. Thermolysin (4.4 yM, Tris 
buffer, pH 7.2, 5% DMF) was incubated at 25° with C1CH2C0-DL-(N-OH)Leu-
OCH^ (4.5 mM) in the presence and absence of the inhibitor Z-Phe-OH 
(1.7 mM) with a reported K^ . of 0.51 mM. This inhibitor binds at the 
active site (Kester and Matthews, 1977). Periodically aliquots were 
assayed for residual enzyme activity. 
Thermolysin (4.2 yM, Tris buffer, pH 7.2) was also incubated at 
25° with ClCH2CO-DL-(N-OH)Leu-OCH3 (0.50 mM, 5% DMF) for 1.5 hr in the 
presence and absence of P-Leu-Trp-OK (49 M ) . These solutions, along with 
a control containing the enzyme and competitive inhibitor only, were 
dialyzed 22 hr against 3 changes of buffer, then assayed for enzyme 
activity. 
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Incorporation of N-(l- C) Chloroacetyl-DL-N-hydroxyleucine methyl 
ester into Thermolysin. A 15 ml solution of purified thermolysin (20 mg) 
14 
was treated with a 1 ml solution of ( C) ClCH2CO-(N-OH)Leu-OCH3 (10 mg/ml) 
containing 10% DMF. The pH of the enzyme-inhibitor solution was then ad­
justed to 7.5 with 0.2 M NaOH. This solution was incubated 1 hr at room 
temperature; however, complete loss of enzymatic activity toward FA-Gly-
Leu-NH2 was achieved after only 10 min. 
Inactivated thermolysin was separated from the excess alkylating 
agent by passage through a 1 x 25 cm column of Sephadex G-25. The con­
centrations of the protein fractions were determined by measuring the 
absorbance of each at 280 nm. The fractions containing the excess alky­
lating agent were located by the characteristic red color produced by 
the addition of 1 drop of a 10% solution of methanolic ferric chloride 
to the fractions following the elution of the protein. The radioactivity 
of the 4 peptide containing fractions was measured. 
14 
A 2 ml sample of a 7.72 yM solution of ( C) thermolysin was dia-
lyzed against 1.0 mM NaOH for 10 hr at 25°. Periodically the radioactiv­
ity in the dialysis tubing was measured on 100 yl aliquots. A 2.5 ml 
14 
sample from the same stock ( C) thermolysin solution was dialyzed against 
a 1.0 M hydroxylamine solution (0.1 M Tris, 1.0 M NaCl, 0.01 M NaCl 2 > pH 
9.0) for 10 days at room temperature. The radioactivity inside the dialy­
sis tubing was measured as before. The possibility of protein leakage 
from the dialysis tubing was checked by measuring the absorbance at 280 nm 
of the solution inside the tubing at the termination of dialysis. 
14 
Cyanogan Bromide Cleavage of ( C) Thermolysin was performed as 
described by Titani et al. (1972a). The lyophilized cleavage peptides 
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were dissolved in 1 ml of 1.0 M formic acid containing 8 M urea and 
chromatographed on a 1 x 50 cm column of Bio-Gel P-100 equilibrated and 
eluted with 1.0 M formic acid. Fractions of 1.8 ml were collected at a 
flow rate of 12 ml per hr. An aliquot (200 yl) from each fraction was 
added to 800 yl of water and the radioactivity present measured. The 
individual fragment peptides were purified by the method of Titani e_t al. 
(1972a). 
Thin Layer Chromatography of Clostridiopeptidase A Cleavage of N-
Carbobenzyloxy-glycyl-L-prolyl-L-leucyl-glycolyl-L-prolinamide. To a 
1.0 ml solution of Z-Gly-Pro-Leu-OCH2CO-Pro-NH2 (1.0 mM, 0.10 M Tris, 
0.01 M CaCl 2, pH 7.2) containing 1% methanol was added 100 yl of a solu­
tion of clostridiopeptidase A (0.01 M calcium acetate) to give a final 
enzyme concentration of 53 yg/ml. Periodically, tic analysis was perform­
ed on 2 yl aliquots by developing on silica gel-G with chloroform-methanol 
(5:1, v/v). The above analysis was performed at pH 8.8, with the same 
enzyme solution after boiling 1 min, and with the substrate solution 
containing 1,10-phenanthroline (10 mM). 
pH-Stat Assay of Clostridiopeptidase A Activity was performed on a 
Radiometer instrument. A typical assay was performed at pH 7.5. To a 
1.0 ml aqueous solution of an appropriate concentration of Z-Gly-Pro-Leu-
OCH2CO-Pro-NH2 containing either 2% DMF of 2% methanol was added 50 yl of 
a clostridiopeptidase A solution (0.01 M calcium acetate). The concentra­
tion of the titrating NaOH was around 0.05 M for all assays. The addition 
of NaOH to maintain pH 7.5 in the substrate solution was followed with 
time after the addition of enzyme. Background hydrolysis of the substrate 
was measured in the absence of enzyme. 
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Determination of K for Z-Gly-Pro-Leu-0CHoC0-Pro-NHo and Clostri-m 2 2 
diopeptidase A. The concentrations of Z-Gly-Pro-Leu-OCH2CO-Pro-NH2 
ranged from 5.0-0.55 mM. The assay concentration of the enzyme was 54 
yg/ml or about 2 yM using a molecular weight of 26,000 for the enzyme 
(Worthington Enzyme Manual, 1972). 
Dependence of the concentration of Clostridiopeptidase A on the 
hydrolysis of Z-Gly-Pro-Leu-OCH2CO-Pro-NH2. The concentration of 
clostridiopeptidase A ranged from 54-10.8 yg/ml in the assay. 
The pH Dependence of and k c a t on the Hydrolysis of Z-Gly-Pro-
Leu-0CHoC0-Pro-NHo by Clostridiopeptidase A. The determination of the K £ £ m 
and k values over the pH range of 6-8.5 was performed with the sub-
C a t 
strate concentrations ranging from 3-0.75 mM and containing 2% methanol. 
The concentration of enzyme was 2.7 yM. The background hydrolysis of 
substrate in the absence of enzyme was measured for each pH value studied. 
pH-stat Assay of Clostridiopeptidase A in the Presence of 1,10-
Phenanthroline and ct-Toluenesulfonyl Fluoride. The concentration of Z-
Gly-Pro-Leu-OCH2CO-Pro-NH2 was 10.2 mM and contained 2% DMF and 1,10-
phenanthroline (8.6 mM) or a-toluenesulfonyl fluoride (10 mM). The assay 
concentration of clostridiopeptidase A was 71 yg/ml. 
Inhibition Studies of Clostridiopeptidase A with Hydroxamic acids, 
Phosphoramidates, Thiol Peptides, and Substrate Hydrolysis Products. To 
1 ml of substrate solution of the appropriate concentration (4 or 1 mM) 
was added 100 yl of the appropriate inhibitor solution (10 - 1 mM). The 
pH was adjusted to 7.5 and 50 yl of clostridiopeptidase A solution 
(0.01 M calcium acetate) was added to give a final enzyme concentration 
of 60 yg/ml. The K values were determined by Dixon plots. 
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Hydrolysis of Z-Gly-Pro-Leu-Gly-Pro-N^ by Clostridiopeptidase A. 
The composition of the reaction mixture was as follows: 0.01 M calcium 
acetate, pH 7.5, 4.1 yM clostridiopeptidase A, and the appropriate 
substrate concentration (7 - 0.9 mM) were placed in a test tube to give 
a total volume of the reaction solution of 1.2 ml containing 4% DMF. 
The assay was carried out at 25° and the reaction was initiated by the 
addition of 100 yl of enzyme solution to the substrate solution. At 
appropriate time intervals, 250 yl of reaction solution were pipetted 
out into a test tube containing 250 yl of 0.1 M HC1 to stop the reaction. 
The amount of a-amino group released was determined colorimetrically at 
570 nm according to the ninhydrin method of Rosen (1957). Glycylprolina-
M 4 -1 -1 
mide was used as the ninhydrin color standard: = 1.05 x 10 M cm 
The hydrolysis was also followed using thin layer chromatography, n-
butanol-acetic acid-water (4:1:1, v/v) was the solvent system used. 
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CHAPTER III 
RESULTS 
Haloacetyl Amino Acid Esters. Earlier studies with carboxypep­
tidase A (Hass and Neurath, 1971a, b) and carboxypeptidase B (Plummer, 
1971) suggested a possible route to the active site directed inhibition 
of thermolysin. The primary specificity for substrate binding for each 
of these metalloproteases is determined by the subsite. Thermolysin 
however does not like a terminal carboxyl group. Therefore the compounds 
BrCH2CO-Phe-OCH3 and BrCH2CO-L-MeLeu-OCH3, containing a favorable 
residue and a blocked carboxyl group, were synthesized as potential 
thermolysin inhibitors. However neither of these compounds measurably 
inhibited thermolysin after 48 hr incubation. The absence of irreversible 
inactivation was probably the result of poor binding to the active site 
of thermolysin since both compounds showed no inhibition of the hydroly­
sis of FA-Gly-L-Leu-NH2. We then decided to extend the peptide chain of 
the inhibitor and synthesized BrCH2CO-L-MeLeu-L-Ala-OCH3. Earlier studies 
with serine proteases and chloromethyl ketones have demonstrated that 
inhibitors with extended peptide chains were more effective and in the 
case of elastase only longer peptide inhibitors would react with the 
enzyme (Powers, 1977). This approach, however, failed with thermolysin 
since no noticeable inhibition was observed with the bromoacetyl dipeptide. 
N-Chloroacetyl-DL-N-hydroxyleucine methyl ester. We next approach-
the problem by searching for good reversible inhibitors of thermolysin 
to which would be attached an alkylating functional group. At about this 
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time peptide hydroxamic acid derivatives were demonstrated to be potent 
inhibitors of thermolysin with values in the yM range (Nishino and 
Powers, 1978). Since the hydroxamic acid moiety of the inhibitors was 
apparently responsible for the increased binding to the enzyme, we in­
vestigated other N-hydroxy compounds. The compound DL-2-hydroxyamino-
4-methylpentanonitrile was a competitive inhibitor of thermolysin (K^ = 
0.10 mM). This led to the synthesis of DL-2-(N-bromoacetyl-N-hydroxy-
amino)-4-methylpentanonitrile which was found to rapidly and irreversibly 
inactivate thermolysin at pH 7.2 (0.10 M Tris, 0.01 M CaCl 2) containing 
5% DMF at 25°. 
Extensive use of the nitrile as an affinity label for thermolysin 
was complicated by its being an oil which was difficult to purify. As a 
result of this undesirable physical property, a search was made for a 
crystalline compound which possessed the N-haloacetyl-N-hydroxy configu­
ration of the nitrile. The required molecule (ClCH2CO-DL-(N-OH)Leu-OCH3) 
had been synthesized by Cook and Slater (1956) but for an entirely 
different purpose. This compound was almost identical in reactivity 
toward thermolysin as the nitrile. 
Kinetics of Inactivation. The active site directed irreversible 
inhibition of an enzyme may be represented by Eq. 1 where the formation 
of a reversible enzyme-inhibitor complex occurs prior to the inactivation 
reaction (Kitz and Wilson, 1970). The observed rate constant 
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of inactivation is a function of inhibitor concentration and can be 
expressed in the convenient reciprocal form given by Eq. 2. By using 
inhibitor concentrations 
K I
 + 1 (2) 
kobs k 3 1 k 3 
in the vicinity of K^ . (the dissociation constant for the reversible 
enzyme-inhibitor complex) it is often possible to determine K^ . and 
(the limiting rate of inactivation) by plotting 1/k , vs l/l. A plot 
obs 
of 1/k , vs l/l for the irreversible inactivation of thermolysin at 
obs 
pH 7.2 by ClCH2CO-DL-(N-OH)Leu-OCH3 using the least squares method gave 
= 7.5 + 2.2 mM and k 3 = 7.5 + 2.0 x 10~ 3 sec" 1 (I * 10.5 - 2.1 mM). 
A similar plot for thermolysin and 2-(N-bromoacetyl-N-hydroxyamino)-4-
_3 
methylpentanonitrile gave = 0.80 + 0.36 mM and k 3 = 7.4+3.3 x 10 
sec 1 (I = 0.87 - 0.12 mM). The limiting rates of inactivation (k 3) were 
essentially identical for the two compounds, but the bromoacetyl-
nitrile was bound 10 fold more tightly by the enzyme. 
Treatment of Thermolysin with q-Bromoisocaproylhydroxamic acid. 
If ClCH2CO-DL-(N-OH)Leu-OCH3 was binding to the active site of thermolysin, 
with the isobutyl group occupying the S^' subsite and coordination of the 
hydroxamic acid to the zinc, then the chloroacetyl group would spend most 
of the time closer to the active site Glu-143 rather than the His-231 
residue. This proximity effect would tend to promote alkylation of the 
Glu-143 carboxylate over the imidazole of His-231. In an attempt to 
distinguish between these two possible sites of alkylation, thermolysin 
was treated with a-bromoisocaproylhydroxamic acid. Assuming again that 
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the isobutyl group would occupy the subsite, with coordination of the 
hydroxamic acid group to the active site zinc atom, the a-bromo group 
would be considerably closer to the His-231 residue than to the carboxy-
late group of Glu-143, promoting alkylation of the imidazole. However, 
the half time of inactivation of thermolysin by a-bromoisocaproylhydrox-
amic was 58 hr, 3 orders of magnitude longer than for the chloroacetyl 
compound. This result was the first indication that the primary site of 
alkylation may not be the His-231 residue but possibly Glu-143. 
Treatment of Thermolysin with N-(3-methyl-l-methoxycarbonylbutyl)-
3-iso-butyloxaziridine and N-Benzylidine-DL-leucine-N-oxide methyl ester. 
These two compounds were synthesized as potential suicide substrates of 
thermolysin. However, thermolysin showed no loss of activity after 3 
days incubation. These compounds showed no binding to thermolysin, in­
dicating that the functionality present had no opportunity to alkylate a 
succeptible active site residue of the enzyme. 
pH Dependence of Inactivation. The pH dependence of the irrever­
sible inactivation of thermolysin by C1CH2C0-DL-(N-OH)Leu-OCH3 was bell 
shaped (Fig. 1) and similar to the pH profile of catalysis reported by 
Pangburn and Walsh (1975). The pH optimum for alkylation was around 7.5. 
The inflection points around pH 7.0 and 7.7 indicate at least two differ­
ent ionizable groups involved in the inactivation of thermolysin. Two 
such groups could possibly be the active site Glu-143 and His-231 (Pang-
burn and Walsh, 1975). However, the pH profile for inactivation of 
thermolysin is complicated by the possible ionization of the N-OH oxygen 
of the inhibitor. Since the inhibitor concentration was of the same 
order of magnitude as the K value, the pH dependence of the limiting 
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Figure 1. pH dependence of the inactivation of 
thermolysin (4.2 yM) by C1CH2C0-DL-(N-OH)Leu-
OCH^ (2.3 mM). The buffers used are described 
in the text. 
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rate of inactivation (kg) cannot be distinguished from the pH dependence 
of binding (K^). As a result, Fig. 1 represents the pH dependence of 
both and K^, and is shown only to illustrate the practical pH range 
for alkylation. 
Active Site Protection of Thermolysin. The inactivation of thermo­
lysin by ClCH2CO-DL-(N-OH)Leu-OCH3 in the presence and absence of the 
competitive inhibitor Z-Phe-OH^ = 0.51 mM) is shown in Fig. 2. The 
presence of the competitive inhibitor resulted in a reduction in the rate 
of inactivation of the enzyme. This inhibitor has been shown by X-ray 
crystallography to bind at the active site (Kester and Matthews, 1977). 
-3 -1 The k , , in the presence of inhibitor was 1.0 x 10 s . The value 
obsd r 
calculated from the equation k , , = k n 1/(KT(1+I/KT)+I) where I is the 
obsd 3 i l 
irreversible inhibitor and I'is Z-Phe-OH, was 0.90 x 10 3 s ^. 
When thermolysin was treated with as little as a 12 fold molar 
excess of the competitive inhibitor P-Leu-Trp-OK(Kyv/0.1 yM) (Komiyama 
et al., 1975J Kam and Powers, unpublished results) immediately prior to 
incubating 1.5 hr in the presence of ClCH2CO-DL-(N-OH)Leu-OCH3, there was 
no detectable loss of enzyme activity due to irreversible inactivation as 
compared with a control following dialysis. A control lacking the com­
petitive inhibitor showed complete loss of enzyme activity after 20 min 
incubation. 
Specificity of the Inhibition. A comparison of the rates of in­
activation of 3 metalloendoproteases by C1CH2C0-DL-(N-0H)Leu-0CH3 (8.4 mM) 
was made in 0.10 M Tris, 0.1 M CaCl 2, pH 7.2 buffer containing 5% DMF at 
25°. The k , /I values of 400, 5.4 and 6.4 M 1 s 1 were observed respec-
obs 
tively for thermolysin, neutral protease A and neutral protease B. 
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Time, min 
Figure 2. Active site protection against inactivation. 
Thermolysin (4.4 yM) in 0.10 M Tris, 0.01 M 
CaCl^, pH 7.2 containing 5% DMF was incubated 
with ClCH2CO-DL-(N-OH)Leu-OCH3 (4.5 mM) in the 
presence (o) and absence (0) of the competitive 
inhibitor Z-Phe-OH (1.7 mM). The enzyme was 
assayed for residual activity as described in 
the text. 
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Neutral proteases A and B from 13. subtilis were irreversibly inhibited 
nearly 2 orders of magnitude slower than thermolysin. Neutral protease 
B hydrolyzed FA-Gly-Leu-NH2 3 times faster than neutral protease A, but 
both these enzymes were alkylated at about the same rate. 
Carboxypeptidase A was irreversibly inhibited by C1CH2C0-DL-(N-0H)-
Leu-OCH^ with a half time of inactivation of more than 3 days. Under the 
same conditions carboxypeptidase A was not measurably inactivated by 
2-(N-bromoacetyl-N-hydroxyamino)-4-methylpentanonitrile. 
Chymotrypsin A^ and subtilisin BPN^showed no measurable loss of 
their enzymatic activities after 3 days of incubation in the presence of 
ClCH2CO-(N-OH)Leu-OCH3 when compared to their controls. 
14 
Incorporation of N-(1- C) Chloroacetyl-DL-N-hydroxyleucine Methyl 
Ester into Thermolysin. The incorporation of carbon 14 labeled CICI^CO-
DL-(N-OH)Leu-OCH^ into thermolysin resulted in 0.97 + 0.03 inhibitor 
molecules attached to 1 enzyme molecule. The 1 to 1 stoichiometry was 
not affected by extended incubation of the enzyme for up to 2 days in the 
presence of the inhibitor following the complete loss of enzymatic activ­
ity. Carbon 14 labeled thermolysin lost 99% of the incorporated radio­
activity after treatment with 1.0 mM NaOH for 8 hr. There was no sig­
nificant recovery of enzymatic activity under these conditions. None 
was expected since a control thermolysin solution lost 99% of its act­
ivity after identical treatment. However, on treatment with 1.0 M hydrox-
ylamine at pH 9.0 in the presence of 0.01 M CaCl 2 the release of radio­
activity was quite slow (t-^/2 = ' T l i e r e w a s n o recovery of therm­
olysin's ability to hydrolyze FA-Gly-L-Leu-NH2; whereas, a control with 
nonalkylated thermolysin retained 18% enzymatic activity after 216 hr in 
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the presence of 1.0 M hydroxylamine and pH 9.0. 
Amino Acid Analysis of Alkylated Thermolysin. Thermolysin was 
alkylated with ClCH^CO-^-OtOLeu-OCH^ and an amino acid analysis was 
performed and compared with that for unlabeled enzyme (available in the 
supplementary material). The analysis was not corrected for the decom­
position of labile amino acids nor for incomplete hydrolysis of the bulky 
residues. The results showed that under the same conditions of hydroly­
sis there was no difference between the amino acid analyses of alkylated 
and nonalkylated thermolysin. Carboxymethyl histidine and carboxymethyl 
tyrosine did not appear in the amino acid analysis of alkylated thermo­
lysin. 
14 
Cyanogen Bromide Cleavage of Thermolysin Alkylated with N-(l C) 
Chloroacetyl-DL-N-hydroxyleucine Methyl Ester. The chromatography pattern 
of the cyanogen bromide cleavage products of alkylated thermolysin on 
Bio-Gel P-100 is shown in Fig. 3. The radioactivity was concentrated in 
the first and third peaks. These two peaks contain both the F^ (residues 
121-205) and F-J-J-J- (residues 1-120) peptides and none of the F ^ (residues 
206-316) fragment (Titani et al.,1972a). Fragment F was purified from 
the third peak by the method of Titani et al., (1972a) which involves 
removal of E^^. by precipitation. The resultant F^ showed a single band 
on gel electrophoresis ( F - Q J is clearly distinguishable). The amino acid 
analysis of the pure F^ . is given in the supplementary material. The 
number of inhibitor molecules attached to the F^ . fragment was determined 
by measuring the radioactivity associated with 7.4 nmol of purified pep­
tide. The amount of peptide used was determined by amino acid analysis 
based on the number of Leu present and the known content of this residue 
(Titani e£ al. , 1972a). Each molecule of F peptide was found to have 0.96 
T r 
F r a c t i o n No. 
Figure 3. Separation of the cyanogen bromide fragments of 
thermolysin on a 1 x 50 cm column of Bio-Gel 
P-100 equilibrated and eluted with 1.0 M formic 
acid. Fractions (1.8 ml) were monitored both 
at 280 nm (solid line) and for radioactivity 
(broken line). Peaks were labeled as described 
by Titani et al. (1972a). 
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inhibitor molecules attached. 
Ester Cleavage of Z-Gly-Pro-Leu-OCH2CO-Pro-NH2 by Clostridiopepti­
dase A. The thin layer chromatography experiments indicated that the 
3 
spot with R f value of 0.65 (Z-Gly-Pro-Leu-OCH2CO-Pro-NH2) diminished 
3 
with time while a new spot (R^ 0.26) identical with glycolylprolinamide 
increased with time following the addition of clostridiopeptidase A at 
pH 7.2 and 25°. A control laking enzyme showed only a single spot 
3 
(R^ 0.65) after 2 days incubation. The presence of 1,10-phenanthroline 
(10 mM) eliminated clostridiopeptidase A cleavage of Z-Gly-Pro-Leu-OCH2CO-
Pro-NH2 as determined by tic. Tris buffer at pH 8.8 in the absence of 
enzyme resulted in the same tic cleavage pattern as in the presence of 
enzyme. Boiling the enzyme solution also eliminated ester cleavage. 
pH-Stat Assay of Clostridiopeptidase A Esterase Activity. The pH-
stat esterase activity of clostridiopeptidase A using Z-Gly-Pro-Leu-
OCH2CO-Pro-NH2 was conveniently performed using either 2% DMF or 2% meth­
anol. However, 5% DMF noticeably inhibited the enzyme, whereas, 5% meth­
anol only resulted in a slight loss of enzymatic activity. A convenient 
enzyme concentration was around 50 ug/ml in the assay. The average back­
ground rate of addition of 0.05 M NaOH was 2.0 x 10 moles sec \ The 
Km for the substrate Z-Gly-Pro-Leu-OCH2CO-Pro-NH2 at pH 7.5 was determined 
to be 1.3 + 0.1 mM. This compares with a Km of 1.5 mM for Z-Gly-Pro-Leu-
Gly-Pro-Gly-0CH3 (Solov' eva et al., 1970) at pH 7.5. The concentration 
dependence of clostridiopeptidase A on the hydrolysis of Z-Gly-Pro-Leu-
OCH2CO-Pro-NH2 is shown in Fig. 4. The hydrolysis of ester is linearly 
dependent on enzyme concentration. The assay is usable easily down to 
10 ug/ml of enzyme in the assay solution. 
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Figure 4. Dependence of the concentration of clostridio­
peptidase A on the hydrolysis of Z-Gly-Pro-Leu-
OCH^CO-Pro-NH^. The concentration of substrate 
was 10.2 mM and contained 2% DMF. The assay 
pH was 7.5. 
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The pH Dependence of K and k _ for the Esterase Activity of 
m cat 
Clostridiopeptidase A is shown in Fig. 5 and is consistent with that 
reported by Yagisawa et^  al_. (1965) for the hydrolysis of Z-Gly-Pro-Leu-
Gly-Pro-OH. The pH range (6-8.5) studied resulted in a negligible de­
crease in hydrolysis rate due to denaturation (Yagisawa et_ al., 1965). 
The value of k was nearly independent of pH over the range chosen, 
cat 
whereas, decreased as the pH increased. Since the substrate is 
neutral, the decrease of Km-values might be due to a dissociable group 
of the enzyme molecule. 
Treatment of Clostridiopeptidase A with 1,10-Phenanthroline and 
a - Toluenesulfonyl Fluoride. As in the case of the tic studies, 1,10-
phenanthroline in the substrate solution inhibited the ester hydrolysis 
of Z-Gly-Pro-Leu-OC^CO-Pro-Nl^ by clostridiopeptidase A by reducing the 
pH-stat rate to background levels. However, after treatment of the 
enzyme with a-toluenesulfonyl fluoride, there was no loss of enzymatic 
activity after incubating 20 min at pH 7.5. It is unlikely, therefore, 
that the ester hydrolysis was due to the presence of contaminating serine 
proteases. 
Inhibition Studies of Clostridiopeptidase A Using the pH-Stat. 
The inhibition results are shown in Table 1. All of the compounds which 
inhibited the enzyme were competitive inhibitors. Consistent with the 
indications that clostridiopeptidase A is a zinc containing metalloendro-
protease, the best inhibitor was the chelating tripeptide Z-Gly-Pro-Leu-
NHOH. This peptide was shown not to be cleaved by clostridiopeptidase A 
using tic methods. As expected, Z-Gly-Gly-Leu-NHOH was a poorer inhibitor 
due to the wellknown preference for a prolyl residue at the P 9 site by 
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6 7 8 
PH 
Figure 5. The pH dependence of K (o) and k (0) 
m cat 
on the esterase activity of clostridiopeptidase 
A. The substrate concentrations ranged from 
3 - 0.75 mM and contained 2% methanol. The 
enzyme concentration was 2.7 uM. 
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Table 1. Inhibition of Clostridiopeptidase A" 
Compound Mode K-j. (mM) 
Glycolylprolimamide Competitive 15 
Z-Gly-Pro-Leu-NHOH Competitive 0.2 
H-Gly-Pro-Leu-(N-HO)Gly-Pro-OH b None — 
Boc-Gly-Pro-Leu-(N-OH)Gly-Pro-OH Competitive 17 
HONHCOCH2CO-Pro-NH2 Competitive 4.6 
Boc-Gly-Pro-Leu-(N-OH)Gly-OEt C None — 
Z-Gly-Pro-Leu-OH Competitive 4.3 d 
Z-Gly-Gly-Leu-NHOH Competitive 18.9 
Z-Gly-Leu-NHOH Competitive 1.5 
HSCH0CH(B )C0-Ala-Gly-NHo 
Z Z Z Competitive 4.4 
P-Ile-Ala-OK b None — 
HONHCOCH(i-Bu)CO-Ala-Gly-NH2 Competitive 4.1 
a. Concentrations of Z-Gly-Pro-Leu-OCH2CO-Pro-NH2 were 4 and lmM and 
contained 2% methanol, pH was 7.5, the concentration of clostridio­
peptidase A was 60 ug/ml. values were determined by Dixon plots. 
b. No inhibition at a maximum inhibitor concentration of 3 mM. 
c. No inhibition at a maximum inhibitor concentration of 1 mM due to 
solubility restrictions. 
d. Yagisawa et al. (1965) report a K T of 4.9 mM. 
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the enzyme. Both products of the ester hydrolysis were reasonably 
good inhibitors of clostridiopeptidase A; with the N-terminal fragment 
being the better inhibitor, with a K^ . comparing favorably with that 
reported by Yagisawa e_t al. (1965) . The good thermolysin inhibitor P-
Ile-Ala-OK showed no binding to clostridiopeptidase A, most likely due 
to the complete absence of prolyl residues and the unfavorable placement 
of an alanyl residue at the P^ site. Significantly the N-substituted 
hydroxamic acid peptides showed no or weak inhibition of clostridiopep­
tidase A. Finally, the alkylating compounds CH^CO-Ala-Ala-Pro-IleCl^Cl 
(1 mM) and C1CH2C0-DL-(N-0H)Leu-0CH3 (1 mM) did not inhibit clostridio­
peptidase A after 3 days incubation. 
The Hydrolysis of Z-Gly-Pro-Leu-Gly-Pro-N^ by Clostridiopeptidase 
A followed by the ninhydrin method resulted in a K of 4.0+1.5 mM. The 
m — 
-3 -1 
k was 2.9 + 1.1 x 10 sec or about 3 times that for the ester which 
cat — 
was 0.89 + 0.02 x 10" 3 sec" 1. The k /K values were 0.73 + 0.11 and 
— cat m — 
0.68 + 0.02 M 1 sec 1 respectively at pH 7.5. A smaller k . value for 
Celt 
the ester in comparison with the peptide is consistent with the results 
for the metalloendoprotease thermolysin and the neutral proteases A and 
B from B. subtilis. 
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CHAPTER IV 
DISCUSSION 
The molecular structures of carboxypeptidase A (Hartsuck and 
Lipscomb, 1971), carboxypeptidase B (Schmid and Herriott, 1976), and 
Thermolysin (Matthews et al., 1972b) have been determined to atomic 
resolution by X-ray crystallography. The active sites of these three 
metalloproteases have many features in common. They include the zinc 
atom which polarizes the scissile peptide bond of a substrate, a glutamic 
acid residue which catalyzes the addition of water to that peptide bond 
and a group which donates a proton to the scissle peptide bond (His in 
thermolysin and probably Tyr in carboxypeptidase). Although detailed 
structural information is not yet available for other important metal­
loproteases such as collagenase or the angiotensin converting enzyme, 
analogous catalytic groups would be expected to be involved in their 
active sites. The individual members of the metalloprotease family 
differ of course in their specificity for peptides or peptide-like 
structures. 
It would be valuable to have available a class of affinity labels 
for metalloproteases which would be both reactive and specific. The 
inhibitors might incorporate a reactive group directed toward one of the 
catalytic groups of a metalloprotease into the structure of a good peptide-
like substrate for a particular metalloprotease. Specificity toward in­
dividual metalloproteases could probably then be achieved by matching the 
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structure of the inhibitor to that of a good substrate of a particular 
metalloprotease. Peptide chloromethyl ketones are one example of a class 
of inhibitors where considerable specificity for individual members of 
the serine protease family can be achieved by alterations in the amino 
acid sequency of the peptide portion of the inhibitor (for a review, 
see Powers, 1977). This research was begun as a first step toward the 
development of such a class of inhibitors for metalloproteases. 
The carboxypeptidase A and B affinity labels which had been previ­
ously described (Hass and Neurath, 1971a and b; Hass et al., 1972) led 
us to snythesize similar compounds in an attempt to extend these inhibi­
tors to the metalloendoprotease thermolysin. However, these compounds 
(BrCH2CO-Phe-OCH3, BrCH2CO-L-MeLeu-OCH3, and BrCH2CO-L-MeLeu-Ala-OCH3) 
showed no indication of being thermolysin inhibitors. It is difficult to 
explain why the first compound (BrCH2CO-Phe-OCH3) was not an inhibitor 
since Gly-Phe-NH2 binds to thermolysin, although the K^ . value is high 
(53 mM) (Feder et^  al_., 1974). This compound may be a substrate of thermo­
lysin with a large K^, the result being that any competitive binding rel­
ative to the assay substrate would not be observed since solubility re­
strictions limited the concentration of the alkylating agent which could 
be utilized. The lack of inhibition by BrCH2CO-L-MeLeu-OCH3 is more 
easily explained in terms of poor binding since the N-methyl group could 
result in severe steric problems at the active site of the enzyme. In 
addition, the replacement of the P^* amide hydrogen with a methyl group 
eliminates the hydrogen bond with the carbonyl oxygen of Ala 113 of 
thermolysin (Weaver je_t al., 1977) . Even extension of the chain of the in­
hibitor to BrCHoC0-L-MeLeu-L-Ala-0CH„ had no effect on the inhibition. 
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Replacement of the P^ amide hydrogen with an hydroxyl group had 
a profound effect on the inhibitory properties of the haloacetyl amino 
acid analogs. Both DL-2-(N-bromoacetyl-N-hydroxyamino)-4-methylpentano-
nitrile and C1CH2C0-DL-(N-OH)Leu-OCH3 bound to and rapidly irreversibly 
inactivated thermolysin. The increased binding of the N-hydroxypeptides 
to thermolysin is probably due to coordinating of the hydroxamic acid 
functional group to the active site zinc atom of thermolysin. The K^ . 
of the bromoacetyl nitrile is 0.80 mM and that of C1CH2C0-DL-(N-OH)Leu-
OCH^ is 7.5 mM while most dipeptide substrates and inhibitors of thermoly­
sin have much higher of K^ . values (Feder et^  al., 1974) . The strong 
reversible binding of a number of other peptide hydroxamic acids to 
thermolysin is also due to interaction of the hydroxamic acid functional 
group with the active site zinc atom (Nishino and Powers, 1978). 
Evidence in support of the binding of 2-(N-bromoacetyl-N-hydroxy-
amino)-4-methylpentanonitrile and C1CH2C0-(N-0H)Leu-0CH3 to the active 
site of thermolysin prior to inactivation was provided by the determina­
tion of the Kj. and values for both compounds. The competitive inhib­
itors P-Leu-Trp-OK and Z-Phe-OH protected thermolysin against inactivation 
by ClCH2CO-DL-(N-OH)Leu-OCH3. This is consistent with the modification 
of an active site residue since Z-Phe-OH and phosphoramidon, which is a 
relative of P-Leu-Trp-OH, have been shown to bind at the active site by 
X-ray crystallography (Kester and Matthews, 1977; Weaver et al., 1977). 
The pH profile of alkylation of thermolysin by C1CH2C0-DL-(N-0H)Leu-0CH3 
closely resembled that for the hydrolysis of FA-Gly-L-Leu-NH2 by the 
enzyme (Pangburn and Walsh, 1975) suggesting the involvement of the same 
residues in substrate hydrolysis and inhibition. Furthermore, the 1 to 1 
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stoichiometry of inactivation is consistent with modification at the 
active site of the enzyme. 
Alkylation of three different residues (Glu-143, Tyr-157, His-231) 
in the active site of thermolysin could be imagined. Since there were no 
differences between the amino acid analyses of alkylated and nonalkylated 
thermolysin, the bond linking the enzyme and the inhibitor must be acid 
labile. This experiment points to formation of an ester between the 
carboxyl group of Glu-143 and the inhibitor (Fig. 6). Alkylation of 
either a histidine or tyrosine would have yielded a stable carboxymethyl 
derivative upon acid hydrolysis. Consistent with ester formation is the 
14 
observation that treatment of thermolysin alkylated with C-labeled 
ClCH2.CO-DL-(N-OH)Leu-OCH3 was sensitive to base since 1 mM NaOH removed 
99% of the incorporated label after an 8 hr treatment. Insignificant 
enzymatic activity (2%) was recovered due to thermolysin's instability 
at pH 11. Hydroxylamine (1M) also slowly displaced the inhibitor from 
the enzyme at pH 9.0. The slow rate is probably due to the inaccessibil­
ity of the occupied active site of the alkylated enzyme. The hydroxamic 
acid which is presumably formed in the reaction is enzymatically inactive 
since no activity toward FA-Gly-L-Leu-NH2 was recovered even though 
thermolysin itself maintained some activity under the conditions of the 
reaction. 
To provide additional evidence that Glu-143 was the site of alky­
lation by ClCH2CO-DL-(N-OH)Leu-OCH3, the labeled enzyme was degraded by 
CN-Br and the F^ . fragment (residues 121-205) was shown to contain the 
14 
( C) inhibitor moiety. The active site His-231 and Asp-226 hydrogen 
bonded to it are part of the F T fragment. Although F also contains 
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H i s - 2 3 1 
Figure 6. Schematic diagram showing the proposed inter­
action between the active site of thermolysin 
and the C1CH2C0-DL-(N-OH)Leu-OCH3 moiety. The 
leucyl side chain of the inhibitor is binding 
to the S^ subsite of the enzyme and the hydrox­
amic functional group is coordinated to the 
zinc atom of thermolysin either as a bidentate 
ligand (shown) or monodentate ligand (not 
shown). The active site Glu-143 has been alky­
lated by the inhibitor. 
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Tyr-157, the hydrolytic removal of the inhibitor with NaOH or 1 M NH^OH 
is clearly only consistent with Glu-143 as the site of the reaction. 
The specificities of 2-(N-bromoacetyl-N-hydroxyamino)-4-methylpen-
tanonitrile and CIC^CO-DL- (N-OH)Leu-OCH3 were examined for a number of 
other proteolytic enzymes. The metalloendoproteases A and B from JB. 
subtilis were rapidly inactivated by both compounds; whereas, the serine 
proteases chymotrypsin A^and subtilisin BPN showed no loss of enzymatic 
activity due to the alkylating agent. The J3. subtilis proteases have a 
substrate specificity very similar to that of thermolysin. Carboxypepti­
dase A was irreversibly inhibited by CIC^CO-DL- (N-OH)Leu-OCH3 at a very 
slow rate (tjy2 > 3 days), but was not inhibited by the bromoacetyl 
nitrile. The inhibition of carboxypeptidase may be due to slow hydrolysis 
of the ester in the buffer with the formation of CIC^CO-DL-(N-OH)Leu-OH 
which would probably be an excellent CPA inhibitor. At present we cannot 
distinguish this possibility from that involving direct inhibition of the 
enzyme by the ester. 
The eventual extension of this new class of metalloendoprotease 
affinity labels to inhibit bacterial collagenase may be greatly aided by 
the development of the convenient and reliable pH-stat assay of clostri­
diopeptidase A activity using the depsipeptide Z-Gly-Pro-Leu-OCH^CO-Pro-
NH^. The assay is particularly amenable to inhibition studies on the 
purified collagenase. The purity of the commercial clostridiopeptidase 
A obtained from Sigma was not examined for the presence of isoenzymes. 
Lwebuga et al. (1976) have isolated four distinct collagenases from 
Clostridium histolyticum. All of the collagenases have comparable 
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catalytic activities against a series of natural and synthetic substrates 
and are immunologically cross-reactive. It is possible that the multi­
plicity of enzyme forms is, at least in part, a consequence of lysis 
following initial secretion from the cell. 
Although thermolysin does not measurably cleave the ester bond of 
Z-Gly-Pro-Leu-OCH2CO-Pro-NH2, as determined with the pH-stat, it does 
cleave the peptide rapidly, presumably between the prolyl-leucyl amide 
bond, as detected by tic methods. However, the ester bond is rapidly 
cleaved by porcine pancreatic elastase (Km = 6.4 + 2.2 mM, kcat = 0.18 + 
0.06 sec ^ ) , precluding the assay of clostridiopeptidase A activity in 
crude extracts. The assay gives easily reproducible results down to 
10 ug/ml (~0.5 uM) . To avoid excessive background hydrolysis, the assay 
should be performed below pH 8.5. 
The inhibition studies with 1,10-phenanthroline and ct-toluene-
sulfonyl fluoride are consistent with clostridiopeptidase A being a 
metalloprotease, typically insensitive to a potent active site directed 
serine protease inhibitor. The chelating tripeptide Z-Gly-Pro-Leu-NHOH, 
based on the potent hydroxamic acid inhibitors of thermolysin, is in fact, 
a better inhibitor of clostridiopeptidase A than Z-Gly-Pro-Leu-OH, in­
dicating the importance of a coordinating ligand to inhibition. The fact 
that the N-substituted hydroxamic acid peptides were, on the whole, very 
poor inhibitors of clostridiopeptidase may be an indication of the mode 
of inhibition by hydroxamic acid peptides in general. The substituted 
hydroxamic acid peptides are not able to tautomerize to the ene-diol, 
which presumably can form from the non substituted hydroxamic acids. The 
ene-diol may be the actual bidentate coordinating species to the active 
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site zinc for both thermolysin and clostridiopeptidase A. If this were 
the case, obviously a bidentate coordinating extended peptide, not re­
quiring tautomerization, should be a very good alternative to the N-
substituted hydroxamic acid peptides. A thiol containing peptide of the 
appropriate sequence would be a likely candidate, since, for example, 
3-mercapto-2-benzylpropionyl-Ala-Gly-NH2, which is far from an optimum 
sequence for a substrate of clostridiopeptidase A, nevertheless was a 
reasonably good inhibitor of the enzyme. 
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CHAPTER V 
CONCLUSIONS 
In conclusion we have reported the first specific irreversible 
inhibitors of metalloendoproteases. The evidence is consistent with 
binding of the inhibitor to the active site of thermolysin with inter­
action of the leucyl side chain with the S ^ subsite and the hydroxamic 
acid functional group (as either a monodentate or bidentate ligand) with 
the active zinc atom. Subsequent alkylation of Glu-143 irreversibly in­
activates the enzyme (Fig. 6). Since a number of non-alkylating peptide 
hydroxamic acids have recently been shown to reversibly bind to several 
metalloproteases (Nishino and Powers, 1978 and unpublished observations), 
haloacetyl-N-hydroxy peptides derived from the appropriate amino acids 
or peptides would be expected to be inhibitors of other metalloproteases. 
The rapid extension of the inhibitors developed for thermolysin 
to the production of potent clostridiopeptidase A inhibitors should be 
greatly assisted by the convenient and reliable pH-stat assay of the 
enzyme's activity we have described. Clostridiopeptidase A, in addition 
to being an endopeptidase, is also an esterase, with kinetic constants 
for ester hydrolysis comparable with those for the analogous peptides. 
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CHAPTER VI 
RECOMMENDATIONS 
Solov1 eva et al. (1970) reported that hydroxy-proline or proline 
replacing leucine in several hexapeptides resulted in an increase in the 
rate of hydrolysis by clostridiopeptidase A. It may be possible to in­
crease the sensitivity of the ester hydrolysis by a similar replacement. 
Since glycolylprolinamide is a substrate of horse liver alcohol dehydro­
genase, it may be possible to couple ester hydrolysis to oxidation of 
the alcohol-peptide produced and follow the increase in absorption due 
to the production of NADH. This approach was not pursued for lack of 
time required to work out the problems inherent in this method. 
The attachment of a fluorescent group to one end of a penta-peptide, 
for example, and a quenching group at the other end, might be useful in 
the spectrofluorimetric assay of clostridiopeptidase A activity. 
Hydrolysis of the peptide would eliminate the intramolecular quenching 
producing a fluorescent fragment. This method, of course, has the poten­
tial of much greater sensitivity than the pH-stat method. 
A potential clostridiopeptidase A affinity label would be 
C1CH2CO-(N-OH)-Gly-Pro-NH2. Other potentially potent reversible in­
hibitors of this enzyme would be structures like: HS-CH2CO-Pro-NH2, Z-Gly-
Pro-NHCH(i-Bu)CS-(N-OH), and Z-Gly-Pro-NHCH(i-Bu)CS-(N-OH)Gly-Pro-NH2. 
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APPENDIX 
The Amino Acid Composition of Thermolysin 
Present Analysis From 
sequence 
Titani F T Titani 
Amino Alkylated et al. d et al. 
Acid Control Enzyme (1972b) F observed (1972a) 
Lys 11 11 11 1.5 1 
His 8 8 8 2.2 2 
Arg 10 10 10 1.4 1 
Asx 44 44 12.7^ 12 
Thr 23 23 b 25 6.6b 6 
Ser 22 2 2 b 26 5.5 b 6 
Glx 22 22 21 7.6 8 
Pro 8 8 8 2.6 3 
Gly 36 36 36 11.1 11 
Ala 28 28 28 7.2 6 
Cys/3 0 0 0 
— 
— 
Val 22 22° 22 5.4 C 6 
Met 2 2 2 — 
H e 15 15 C 18 6.9° 8 
Leu 16 16 16 5.0 5 
Tyr 26 2 6 b 28 5.7
b 5 
Phe 8 8 b 10 3.1 3 
Trp — — 3 — — 
The balues were for 24 hr hydrolysates. Calculations were vased on 28 
residues of Ala per molecule. 
*No correction was made for decomposition of the amino acid. 
"No correction was made for the incomplete hydrolysis of the amino acid. 
^Calculations were based on 5 residues of Leu per molecule. 
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